Search

Your search keyword '"Ivancevich, J. C."' showing total 145 results

Search Constraints

Start Over You searched for: Author "Ivancevich, J. C." Remove constraint Author: "Ivancevich, J. C."
145 results on '"Ivancevich, J. C."'

Search Results

1. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

2. Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

3. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

4. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

5. The ARIA-MeDALL hypothesis

6. Physicians' preferences in the use of PROMs during asthma and allergic rhinitis clinical approach

7. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

8. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

9. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

10. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

11. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®

12. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper

13. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

14. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

15. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

16. Treatment of allergic rhinitis during and outside the pollen season using mobile technology : A MASK study

17. Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing

18. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

19. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

20. Clinical practice guide for anaphylaxis in Latin America (Galaxia-Latam) Guía de Actuación en Anafilaxia en Latinoamérica (Galaxia-Latam)

21. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

22. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

23. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

24. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

25. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

26. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

27. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

28. MASK 2017 : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.

29. Daily allergic multimorbidity in rhinitis using mobile technology : A novel concept of the MASK study

30. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study.

31. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

32. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.

33. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

34. Erratum to : Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

35. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.

36. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

37. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

38. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

39. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

40. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

41. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

42. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

43. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( MACVIA ‐ ARIA ) ‐ EIP on AHA Twinning Reference Site ( GARD research demonstration project)

44. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

45. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

46. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 Area 5)

47. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3

48. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 Area 5)

49. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

50. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.

Catalog

Books, media, physical & digital resources